Parameta and ICE expand OTC data feed to cover 600+ streams

TP ICAP's data arm pipes exclusive OTC pricing into ICE's consolidated feed, broadening transparency across rates, credit, FX and energy markets.

A large, modern trading office features rows of desks, each with multiple computer monitors displaying financial charts, illuminated by natural light from a wall of windows and the screens' glow.

Parameta Solutions, the data and analytics arm of interdealer broker TP ICAP, has agreed an expanded distribution deal with Intercontinental Exchange (NYSE: ICE) that will route exclusive, real-time over-the-counter pricing from ICAP, Tullett Prebon and PVM directly into the ICE Consolidated Feed. The move brings hard-to-source OTC market intelligence into a normalised stream already aggregating content from more than 600 data sources, reaching banks, asset managers, hedge funds and independent software vendors in a single integration.

OTC markets sit at the less visible end of the trading spectrum. Unlike exchange-listed instruments, OTC transactions are negotiated bilaterally between counterparties, which means pricing and liquidity data have historically been fragmented, proprietary and difficult to consolidate. Parameta says it is the exclusive provider of OTC pricing from TP ICAP's brokerage network, which the parent group positions as the world's largest interdealer broker. The asset classes now covered through the ICE feed span linear and non-linear rates, inflation, fixed income, credit, foreign exchange and FX options, money markets, and energy.

Closing the transparency gap in OTC markets

"Many firms want a clearer and more complete view of markets beyond the exchanges, but without adding complexity to their data infrastructure," said Lisa Ward, Head of Channel Distribution at Parameta Solutions. "By combining the depth of liquidity and market expertise within TP ICAP Group with ICE's global distribution capabilities, we are making hard-to-source OTC market data more accessible, usable and actionable."

The practical appeal for buy-side institutions is straightforward: rather than maintaining separate data pipelines for exchange-traded and OTC instruments, clients receive a combined view through their existing ICE workflow. For risk managers and treasury desks pricing multi-leg derivatives or cross-currency swaps, the ability to cross-reference exchange and OTC prices in a single normalised feed can reduce latency and operational overhead in post-trade reconciliation.

Convergence of market infrastructure and data economics

The deal illustrates a broader structural shift in financial market infrastructure: data has become as strategically valuable as execution capacity. ICE itself has evolved from a pure exchange operator into a multi-asset data business, with fixed income data services and mortgage technology now material revenue lines. Expanding the Consolidated Feed's OTC coverage reinforces that trajectory, deepening the stickiness of ICE's data subscription base at a time when rival operators such as Bloomberg and Refinitiv (now LSEG Data & Analytics) are competing aggressively on feed breadth.

For TP ICAP, licensing OTC data through a third-party aggregator of ICE's scale extends its commercial reach without requiring the interdealer broker to build a competing distribution network. This asset-light model mirrors approaches taken across financial data infrastructure: proprietary data sources (trading venues, clearinghouses, specialist brokers) increasingly monetise their information advantage by plugging into dominant distribution rails rather than trying to own the entire stack.

The wider read-across touches the regulatory landscape too. Post-crisis transparency rules across jurisdictions (MiFID II in the EU, comparable regimes in the US and Asia-Pacific) have created persistent demand for consolidated, auditable pricing records in OTC instruments. Any expansion of standardised OTC data distribution addresses a regulatory compliance use case as much as a trading one, which lowers institutional barriers to adoption and keeps the product relevant for risk and compliance teams, not just traders.

Whether this partnership accelerates consolidation pressure on smaller, standalone OTC data vendors remains an open question. As the two largest interdealer and exchange-infrastructure franchises align their data layers, the competitive floor for independent fixed income and derivatives data providers is likely to rise.